NCT06941909 is a NA clinical trial of Mindfulness-Based Self-Compassion in Care Givers, sponsored by Neslihan Lok.

Who is sponsoring NCT06941909?

NCT06941909 is sponsored by Neslihan Lok.

What drugs are being tested in NCT06941909?

Interventions in NCT06941909: Mindfulness-Based Self-Compassion.

What condition does NCT06941909 study?

NCT06941909 studies Care Givers, Burden, Caregiver, Stress, Satisfaction With Life.

Is NCT06941909 still recruiting?

NCT06941909 is currently completed. Last updated 24 April 2025.

Last reviewed 2025-04-24 · How we verify

NCT06941909

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of a Mindfulness-Based Self-Compassion Program on Care Burden, Life Satisfaction, and Coping Levels of Caregivers of Individuals With Schizophrenia

Completed NA Last updated 24 April 2025

What this trial tests

NA trial testing Mindfulness-Based Self-Compassion in Care Givers in 44 participants. Completed in 24 March 2025.

Timeline

13 January 2024

Primary endpoint
20 January 2024

24 March 2025

Quick facts

Lead sponsor	Neslihan Lok
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	44
Start date	13 January 2024
Primary completion	20 January 2024
Estimated completion	24 March 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Mindfulness-Based Self-Compassion

Conditions studied

Care Givers — all drugs for Care Givers →
Burden, Caregiver — all drugs for Burden, Caregiver →
Stress — all drugs for Stress →
Satisfaction With Life — all drugs for Satisfaction With Life →

Sponsor

Neslihan Lok

Who can join

18 and older, any sex, with Care Givers or Burden, Caregiver. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to examine the effect of the Mindfulness-Based Self-Compassion Program on caregiver burden, life satisfaction, and coping with stress levels among caregivers of individuals diagnosed with schizophrenia. This is a randomized controlled trial with a parallel-group design. The study sample consists of caregivers of individuals diagnosed with schizophrenia who have applied to the psychiatry outpatient clinic of a university hospital within the past year. Caregivers who meet the inclusion criteria will be randomly assigned to intervention and control groups. The program was delivered over eight weeks through group training and counseling sessions. The findings of this study are expected to guide the development of interventions targeting caregiver burden, life satisfaction, and coping strategies among caregivers. Research Hypotheses H1.1: The caregiver burden of the intervention group receiving the Mindfulness-Based Self-Compassion Program is lower than that of the control group. H1.2: The life satisfaction of the intervention group receiving the Mindfulness-Based Self-Compassion Program is higher than that of the control group. H1.3: The coping level of the intervention group receiving the Mindfulness-Based Self-Compassion Program is higher than that of the control group. H1.3.1: The self-confident coping approach of the intervention group is higher than that of the control group. H1.3.2: The optimistic coping approach of the intervention group is higher than that of the control group. H1.3.3: The tendency to seek social support in the intervention group is higher than in the control group. H1.3.4: The helpless coping approach of the intervention group is lower than that of the control group. H1.3.5: The submissive coping approach of the intervention group is lower than that of the control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Care Givers

Currently open trials in the same condition.

NCT06905119 — Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience · NA · recruiting

Other Neslihan Lok trials

Trials by the same sponsor.

NCT07522125 — Effects of a Multicomponent Exercise Program on Frailty, Cognitive Function, and Sleep Quality in Older Adults · NA · completed
NCT06935981 — Effectiveness of School-based Mental Health Program · NA · completed
NCT06883734 — The Effect of Illness Management Skill Training Applied to Patients With Schizophrenia · NA · completed
NCT07017881 — The Effectiveness of Psychosocial Skills Training Applied to Individuals Diagnosed With Schizophrenia · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06941909 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Neslihan Lok
Last refreshed: 24 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06941909.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing